0515 Awake endoscopy optimizes tolerance and effectiveness of hypoglossal nerve stimulation

Abstract Introduction Hypoglossal nerve stimulation(HGNS) which has been available and FDA approved since 2014 in the US may allow for effective treatment of obstructive sleep apnea(OSA) patients without concentric collapse on Drug induced Sleep Endoscopy other clinical parameters who have failed CPAP. Tolerance stimulation be problematic a subset not allowing them to adhere therapy. Although there are currently clinically authoritative studies regarding role awake endoscopy management such patients, visualizing what comfortable settings that tongue protrusion while potentially upper airway obstruction office setting might serve as surrogate ensuring optimization during patients' this is retrospective review at Tufts Medical Center Boston MA. Methods A chart were implanted with HGNS device (Inspire TM) did tolerate therapy proceeded optimize allowed tolerance or comfort analyzed. Patients had part assessment any time course their evaluations included review. Results Out 129 Boston, MA, 13 (Approximately 10 % total number patients) noted above. these improved adherence OSA subsequently management. Conclusion remain adherent after strategically performing adequacy outpatient setting. This indicates selected patients. Support (if any) None